Maura Fagan MD
Assistant Professor, Infectious Diseases
771 Albany St | (617) 414-4198
Dr. Fagan is an Assistant Professor of Medicine at Boston University. She is the medical director of the inpatient medical service of the Section of Infectious Diseases. She is a member of the Department of Medicine Inpatient Leadership Group and of the Antibiotic Subcommittee of the Pharmacy and Therapeutics Committee. Her clinical interests include HIV, infective endocarditis, and outpatient parenteral antibiotic therapy.
MD, Boston University School of Medicine, 1987
BA, Wellesley College, 1983
Jawa R, Rozansky H, Clemens D, Fagan M, Walley AY. Rethinking Home-based Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Drugs: An Opportunity for Change in the Time of COVID-19. J Addict Med. 2021 Apr 09. PMID: 33870955.Published on 7/25/2020
Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33. PMID: 32721528.Published on 9/18/2019
Carneiro TS, Awtry E, Dobrilovic N, Fagan MA, Kimmel S, Weinstein ZM, Cervantes-Arslanian AM. Neurological Complications of Endocarditis: A Multidisciplinary Review with Focus on Surgical Decision Making. Semin Neurol. 2019 08; 39(4):495-506. PMID: 31533190.Published on 12/1/2015
Sequeira S, Morgan JR, Fagan M, Hsu KK, Drainoni ML. Evaluating Quality of Care for Sexually Transmitted Infections in Different Clinical Settings. Sex Transm Dis. 2015 Dec; 42(12):717-24. PMID: 26562703.Published on 12/1/1994
Fagan MA, Liu Y, Stütz P, Vyplel H, Golenbock DT. Acyclic analogue of lipid A stimulates TNF-alpha and arachidonate release via a unique LPS-signaling pathway. J Immunol. 1994 Dec 1; 153(11):5230-8. PMID: 7525728.